Vir Biotechnology, Inc. VIR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Product | ||||||
| Grant revenue | $12K-96.1% | $310K+1.6% | $305K+66.7% | $183K-85.2% | $1.24M+13.0% | |
| License and collaboration revenue | -$41K— | —— | —— | —— | -$70K-100% | |
| Other revenue | $0— | —— | —— | —— | $1.86M+218% | |
| Total segment and consolidated revenue by Geography | ||||||
| Foreign | -$41K— | —— | —— | —— | $1.86M— | |
| U.S. | $12K— | —— | —— | —— | $1.24M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Vir Biotechnology, Inc. break its business down?
- Vir Biotechnology, Inc. (VIR) reports total revenues by product across 3 parts — Grant revenue, License and collaboration revenue and Other revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Vir Biotechnology, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Vir Biotechnology, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.